Indeed, ATGL overexpression represses proliferation of melanoma, colon carcinoma, HCC, and lung cancer cell lines [117,118], and also enhances the response of anti-cancer agents against HCC cell lines [118]. This evidence concerns the gene PNPLA2 and hepatocellular carcinoma.